Mark Sedrak
Kaiser Permanente
17 Papers
29 Citations
Mark Sedrak is an academic researcher from Kaiser Permanente. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 4, co-authored 17 publications. Previous affiliations of Mark Sedrak include Stanford University.
Chat about Author
Papers
Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study.
Jerrold L. Vitek,Roshini Jain,Lilly Chen,Alexander I. Tröster,Lauren E. Schrock,Paul A. House,Monique Giroux,Adam O Hebb,Sierra Farris,Donald Whiting,Timothy Leichliter,Jill L. Ostrem,Marta San Luciano,Nicholas B. Galifianakis,Leo Verhagen Metman,Sepehr Sani,Jessica A. Karl,Mustafa S. Siddiqui,Stephen B. Tatter,Ihtsham Haq,Andre G. Machado,Michal Gostkowski,Michele Tagliati,Adam N. Mamelak,Michael S. Okun,Kelly D. Foote,Guillermo Moguel-Cobos,Francisco A. Ponce,Rajesh Pahwa,Jules M. Nazzaro,Cathrin M. Buetefisch,Robert E. Gross,Corneliu C. Luca,Jonathan R. Jagid,Gonzalo J. Revuelta,Istvan Takacs,Michael H. Pourfar,Alon Y. Mogilner,Andrew P. Duker,George T. Mandybur,Joshua M. Rosenow,Scott E. Cooper,Michael C. Park,Suketu M. Khandhar,Mark Sedrak,Fenna T. Phibbs,Julie G. Pilitsis,Ryan J. Uitti,Philip A. Starr +48 more
TL;DR: This double-blind, sham-controlled, randomised controlled trial provides class I evidence of the safety and clinical efficacy of subthalamic nucleus DBS with a novel multiple independent contact current-controlled (MICC) device for the treatment of motor symptoms of Parkinson's disease.
119
Outcomes of a Multicenter, Prospective, Crossover, Randomized Controlled Trial Evaluating Subperception Spinal Cord Stimulation at ≤1.2 kHz in Previously Implanted Subjects.
James North,Eric Loudermilk,Albert Lee,Harsh Sachdeva,Demetrios Kaiafas,Edward Washabaugh,Samir J Sheth,James Scowcroft,Nagy Mekhail,Benjamin Lampert,Thomas L. Yearwood,Erik Shaw,Joseph N. Atallah,Carroll McLeod,John J. Han,Cong Yu,Mark Sedrak,Rene Lucas,Andrew Trobridge,Joseph Hegarty,Nathan Miller,Lilly Chen,Roshini Jain +22 more
TL;DR: The WHISPER randomized controlled trial (RCT) evaluates safety and clinical effectiveness of subperception spinal cord stimulation (SCS) at ≤1.2 kHz in subjects previously implanted with an SCS system for treatment of chronic, neuropathic pain.
38
Trigeminal and sphenopalatine ganglion stimulation for intractable craniofacial pain--case series and literature review
Arsani William,Tej D. Azad,Eliezer Brecher,Taissa Cherry,Ivan Bernstein,Diana Bruce,Stacey Rohrer,Zachary A. Smith,Mary William,Eric Sabelman,Gary Heit,Patrick Pezeshkian,Mark Sedrak +12 more
TL;DR: Refractory facial pain may respond positively to ganglionic forms of stimulation, and it appears safe and durable to implant electrodes in the pterygopalatine fossa via a lateral transpterygoid approach.
26
Double blind randomized controlled trial of deep brain stimulation for obsessive-compulsive disorder: Clinical trial design.
Nicole C.R. McLaughlin,Nicole C.R. McLaughlin,Darin D. Dougherty,Emad N. Eskandar,Herbert E. Ward,Kelly D. Foote,Donald A. Malone,Andre G. Machado,William Wong,Mark Sedrak,Wayne K. Goodman,Brian H. Kopell,Fuad Issa,Donald C. Shields,Osama A. Abulseoud,Kendall H. Lee,Mark A. Frye,Alik S. Widge,Alik S. Widge,Thilo Deckersbach,Michael S. Okun,Dawn Bowers,Russell M. Bauer,Dana M. Mason,Cynthia S. Kubu,Ivan Bernstein,Kyle A.B. Lapidus,David L. Rosenthal,Robert L. Jenkins,Cynthia Read,Paul Malloy,Paul Malloy,Stephen Salloway,Stephen Salloway,David R. Strong,Richard N. Jones,Steven A. Rasmussen,Steven A. Rasmussen,Benjamin D. Greenberg,Benjamin D. Greenberg,Benjamin D. Greenberg +40 more
TL;DR: The study was conducted over a six-year period and was a NIH-funded, eight-center sham-controlled trial of DBS targeting the ventral capsule/ventral striatum (VC/VS) region.
11
A novel mesial temporal stereotactic coordinate system
TL;DR: A novel stereotactic coordinate system based on mesial temporal anatomical landmarks to facilitate operative planning, improve surgical outcomes, and standardize outcome assessment is presented.
9